Paper
0
Comparative Effectiveness of Linvoseltamab Versus Current Real-World Standard of Care Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Treated at IMWG Sites
Authors
Shaji Kumar,Sundar Jagannath
Katja Weisel,Laura Dachs,Meletios Dimopoulos,David Siegel,Jorge Monge,Xavier Leleu,Juan Du,Javier Rubia,Jae Lee,María-Victoria Mateos,Alessandro Gozzetti,Dominik Dytfeld,Enrique Ocio,Joan Bladé,Shuji Ozaki,Madhu Nagaraj,Rafla Hassan,J. Green,Glenn Kroog,Karen Lorenc,Christian Hampp,Qiufei Ma
+22 authors
,Brian DurieJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave